Ligand validation:7AVN

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7AVN_LFA_B_306	27%	98%	0.144	0.828	0.12	0.17	-	-	1	0	80%	1
7AVN_LFA_A_309	27%	99%	0.148	0.81	0.11	0.13	-	-	1	0	90%	1
7AVN_LFA_A_302	26%	98%	0.137	0.812	0.14	0.15	-	-	0	0	80%	1
7AVN_LFA_B_305	25%	99%	0.131	0.891	0.1	0.11	-	-	0	0	30%	1
7AVN_LFA_B_304	23%	98%	0.15	0.809	0.17	0.1	-	-	0	0	80%	1
7AVN_LFA_B_303	22%	99%	0.135	0.838	0.12	0.11	-	-	0	0	50%	1
7AVN_LFA_B_301	21%	99%	0.138	0.854	0.12	0.12	-	-	0	0	40%	1
7AVN_LFA_A_305	19%	100%	0.128	0.83	0.09	0.1	-	-	0	0	40%	1
7AVN_LFA_A_304	17%	99%	0.133	0.838	0.11	0.13	-	-	0	0	30%	1
7AVN_LFA_B_312	15%	99%	0.157	0.807	0.11	0.11	-	-	1	0	50%	1
7AVN_LFA_B_307	14%	99%	0.171	0.796	0.1	0.1	-	-	2	0	60%	1
7AVN_LFA_B_311	14%	98%	0.13	0.799	0.14	0.14	-	-	0	0	35%	1
7AVN_LFA_A_303	14%	98%	0.174	0.814	0.13	0.14	-	-	0	0	50%	1
7AVN_LFA_B_302	13%	99%	0.166	0.808	0.12	0.09	-	-	2	0	40%	1
7AVN_LFA_B_310	12%	99%	0.163	0.807	0.12	0.09	-	-	0	0	35%	1
7AVN_LFA_A_306	11%	99%	0.177	0.759	0.12	0.08	-	-	0	0	60%	1
7AVN_LFA_A_308	10%	99%	0.193	0.784	0.13	0.1	-	-	0	0	50%	1
7AVN_LFA_B_309	10%	98%	0.147	0.75	0.13	0.13	-	-	0	0	40%	1
7AVN_LFA_A_313	8%	98%	0.152	0.757	0.15	0.11	-	-	1	0	30%	1
7AVN_LFA_A_311	8%	99%	0.14	0.743	0.11	0.13	-	-	0	0	30%	1
7AVN_LFA_A_301	8%	98%	0.179	0.744	0.16	0.1	-	-	0	0	50%	1
7AVN_LFA_B_313	8%	99%	0.144	0.737	0.11	0.12	-	-	2	0	30%	1
7AVN_LFA_A_310	7%	99%	0.171	0.752	0.13	0.08	-	-	2	0	30%	1
7AVN_LFA_A_307	6%	99%	0.185	0.694	0.12	0.12	-	-	0	0	50%	1
7AVN_LFA_B_308	5%	99%	0.157	0.688	0.09	0.14	-	-	2	0	30%	1
7AVN_LFA_A_312	4%	100%	0.18	0.615	0.08	0.1	-	-	3	0	65%	1
5JSI_LFA_B_304	54%	78%	0.118	0.917	0.25	0.62	-	-	1	0	80%	1
8RSO_LFA_B_501	41%	99%	0.095	0.926	0.1	0.12	-	-	0	0	35%	1
7Q37_LFA_A_309	34%	93%	0.174	0.882	0.24	0.26	-	-	0	0	85%	1
7AVO_LFA_B_306	33%	81%	0.154	0.866	0.29	0.52	-	-	4	0	80%	1
9G16_LFA_A_511	29%	99%	0.123	0.88	0.1	0.13	-	-	0	0	45%	1
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	0	75%	1
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	1
8R98_LFA_A_401	55%	100%	0.089	0.937	0.09	0.08	-	-	0	0	55%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.